Doping Case Against Russian Figure Skater Kamila Valieva Resumes at Court of Arbitration for Sport

Valieva originally declared "no fault or negligence" in alleged doping incident, with various international sports bodies now challenging this ruling - final decision could impact allocation of 2022 Olympic medals and future of Russian anti-doping measures.

• The Court of Arbitration for Sport (CAS) is resuming its hearing on the doping case involving the Russian figure skater Kamila Valieva, who tested positive for the endurance-boosting heart medicine trimetazidine during the 2022 Winter Olympics in Beijing.
• Following the figure skating team event in 2022, no medals were allocated, with Valieva's team, which was competing as the Russian Olympic Committee, initially finishing first - the case's final decision could impact those allocations.
• Originally, the Russian Anti-Doping Agency (RUSADA) declared that Valieva bore no "fault or negligence" in the incident and the skater defended that the drug was taken unknowingly.
• RUSADA's initial ruling is being challenged by the International Olympic Committee (IOC), the International Skating Union (ISU), and RUSADA itself - the agency has since changed its stance and is now seeking a penalty for Valieva that may include a reprimand.
• The World Anti-Doping Agency (WADA) is seeking a four-year ban for Valieva that would invalidate her results from the Beijing Games, potentially denying the Russian Olympic Committee their team event gold medal.

3 Articles

CNN Reuters CNA